Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
49
# OF OVERLAPPING
HOLDINGS
IBB
260
HOLDINGS
24%
ALSO IN WDNA
WDNA
85
HOLDINGS
62%
ALSO IN IBB
SECTOR DRIFT (IBB minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.7% | 2.9% | 2.7% |
|
AMGEN INC | 7.6% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 7.8% | 1.7% | 1.7% |
|
UNITED THERAPEUTICS CORP | 1.7% | 2.3% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 8.7% | 1.4% | 1.4% |
IBB Overweight Relative to WDNA
|
VERTEX PHARMACEUTICALS INC | 7.3% |
|
GILEAD SCIENCES INC | 6.0% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
AMGEN INC | 5.4% |
|
ALNYLAM PHARMACEUTICALS INC | 4.0% |
|
INSMED INC | 3.2% |
|
BEIGENE LTD. SPONSORED ADR | 2.1% |
|
INCYTE CORP | 1.8% |
 |
ARGENX SE ADR | 1.7% |
|
BIOGEN IDEC INC | 1.7% |
IBB Underweight Relative to WDNA
|
ELI LILLY & CO | -3.1% |
|
JOHNSON & JOHNSON | -2.7% |
|
PFIZER INC | -2.4% |
|
STOKE THERAPEUTICS, INC. | -2.4% |
|
REGENXBIO, INC. | -2.2% |
 |
NOVO NORDISK A/S-B | -2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.1% |
|
NOVOZYMES A/S-B SHARES | -2.0% |
|
BEAM THERAPEUTICS, INC. | -1.9% |
|
IMMUNOME, INC. | -1.9% |